We've made it easier for you to connect! Fill out your NEW profile.
Breastcancer.org is hiring! Read the job posting: Virtual Support Group Facilitator and Community Moderator
Diagnosed Young? We'd love your answers to these questions.

Keytruda Improves Survival in Triple-Negative Breast Cancer

Keytruda Improves Survival in Triple-Negative Breast Cancer

September 15, 2024

People diagnosed with early-stage triple-negative breast cancer who received the immunotherapy Keytruda (chemical name: pembrolizumab) along with chemotherapy before and after surgery had better event-free survival — how long they lived without the cancer coming back. Read more…